Last, it is possible that true HCC-related common SNPs at MALAT-1 may not be included in the catalog of variants, or MALAT-1 low frequency variants potentially having stronger effects on HCC risk have not been explored. This evidence concerns the gene MALAT1 and hepatocellular carcinoma.